Grounds crew workers Jacob Weiderstrom, left, and Marcus Gignac pull a tarp off home plate as they continue to keep the Seattle Mariners' field in playing shape as the ballpark goes into its seventh week without baseball played because of the coronavirus outbreak Monday, May 11, 2020, in Seattle. (AP Photo/Elaine Thompson)
By Ronald Blum
The baseball players' association gave management a wide-ranging response Thursday to a 67-page proposed set of protocols for a season to be played during the coronavirus pandemic.
Management had presented the union and the 30 teams the proposed draft last Friday.
The union said Thursday it addressed: protections for high-risk players, access to pre- and postgame therapies, testing frequency, protocols for positive tests, in-stadium medical personnel, and sanitization procedures.
Players viewed many of the concepts in the original draft as over-the-top, such as arriving in uniform at the ballparks, a prohibition on them leaving hotels without team permission, and a ban on guests other than immediate family members. Players also objected to a ban on the use of showers and hydrotherapy.
The union wants more frequent testing than management's proposed “multiple times per week.”
MLB is expected to make an economic proposal to the union within a few days. MLB hopes to start the season by early July.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
